It is now generally accepted philosophy in the addiction treatment community that customized treatment plans that address each patient’s individual substance abuse history are crucial for success. A new study from researchers at Yale University may now be taking this philosophy one step further through exploration of gene variants to treat opioid addiction patients. Led by Yale student Andrew H. Smith, the study was funded largely by the National Institute on Drug Abuse and shed some interesting light on the role of genetics in the continued innovation of treatment for chemical dependency. It was published on January 24th in the journal Molecular Psychiatry.
Can Gene Variants Create More Targeted Opioid Addiction Treatment? posted first on http://blog.recoveryunplugged.com
No comments:
Post a Comment